Bruce goldsmith passage bio
WebJun 1, 2024 · PHILADELPHIA, June 01, 2024 (GLOBE NEWSWIRE) - Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system (CNS) disorders, today announced the election of Derrell D. Porter, M.D., to its board of directors and his … WebAs Chief Executive Officer and President at PASSAGE BIO INC, Bruce Goldsmith Ph.D. made $5,288,384 in total compensation. Of this total $550,000 was received as a salary, $242,000 was received as a bonus, $4,480,759 was received in stock options, $0 was awarded as stock and $15,625 came from other types of compensation.
Bruce goldsmith passage bio
Did you know?
WebBruce A. Goldsmith, Ph.D., has served as the Company’s Chief Executive Officer and President and as a member of the Company’s Board of Directors since January 2024. … WebMay 9, 2024 · Passage Bio, Inc. (NASDAQ:NASDAQ:PASG) Q1 2024 Earnings Conference Call May 5, 2024 8:30 AM ETCompany ParticipantsStuart Henderson - Vice President of Investor Relations and Strategic...
WebJan 10, 2024 · “In 2024 we set out to advance, diversify and broaden our pipeline, and we were successful,” said Bruce Goldsmith, Ph.D., president and chief executive officer, Passage Bio. WebFeb 22, 2024 · Bruce Goldsmith, PhD, Passage Bio president and CEO. Passage Bio is doubling down on its lead clinical program, a gene therapy designed to treat GM1 …
WebBruce Goldsmith, Ph.D. President and Chief Executive Officer Passage Bio, Inc. Two Commerce Square 2001 Market Street, 28th Floor Philadelphia, PA 19103 (Name and Address of Agent for Service) (267) 866-0311 (Telephone number, including area code, of agent for service) Please send copies of all communications to: Effie Toshav, Esq. … WebJan 28, 2024 · Dr. Bruce Goldsmith joins Passage Bio from Deerfield Management where he was a venture partner responsible for early-stage investments and …
WebMay 16, 2024 · Passage Bio, Inc. (NASDAQ:NASDAQ:PASG) Q1 2024 Earnings Conference Call May 16, 2024 8:30 AM ETCompany ParticipantsStuart Henderson - …
WebMar 15, 2024 · Bruce Goldsmith, president and chief executive officer of Passage Bio, said the tough decision to initiate layoffs and reduce operating expenses, along with the decision to align its partnership with the University’s gene therapy program, will provide the company with the ability to “execute against our ongoing clinical trials and advance ... dream of casket meaningengino 3d interactive instructionsWebJun 1, 2024 · Bruce Goldsmith, Ph.D. to step down as president and chief executive officer and member of board of directors, will serve as a strategic advisor for a transition period Edgar B. (Chip) Cale, current general counsel and corporate secretary, appointed as … enginlish to tamilWebView Bruce Goldsmith’s profile on LinkedIn, the world’s largest professional community. Bruce has 12 jobs listed on their profile. ... Passage Bio Jan 2024 - Jun 2024 2 years 6 … engino architecture setWebJan 28, 2024 · Previously, Dr. Goldsmith was chief operating officer at Lycera, a company developing first-in-class small molecules for immuno-oncology and autoimmune … dream of car underwaterWebDec 17, 2024 · Passage Bio (NASDAQ: PASG) has leased about 62,000 square feet of lab space at the campus, which is intended to support analytics, process development, quality control and pilot manufacturing. dream of chang\u0027anWebMar 15, 2024 · “We are committed to our mission of developing transformative therapies for people with devastating CNS disorders,” said Bruce Goldsmith, Ph.D., president and chief executive officer, Passage Bio. dream of car wreck